Skip to main content

Advertisement

SpringerLink
Log in

Natural endogenous ligands for benzodiazepine receptors in hepatic encephalopathy

  • Original Paper
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

Benzodiazepines of natural origin (NBZDs) have been found in human blood and brains as well as in medicinal plants and foods. In plasma and brain tissue there are i.e. diazepam and nordiazepam equal to commercial drugs but there are also other benzodiazepine-like compounds termed “endozepines”, which act as agonists at the benzodiazepine receptors of central type (CBR). A synthetic pathway for the production of NBZDs has not yet been found, but it has been suggested that micro-organisms may synthesize molecules with benzodiazepine-like structures. Hence NBZDs could be of both endogenous and exogenous source and be considered as natural anxyolitic and sedative. Interestingly there are also natural compounds, such as the polypeptide Diazepam Binding Inhibitor (DBI) acting as an “inversive agonist” implicated in fair and panic disorders. It has been suggested that NBZDs may play a role in the pathogenesis of hepatic encephalopathy (HE). Multidirectional studies evaluated NBZDs levels (1) in the blood of normal subjects, of cirrhotic with or without HE and in commercial benzodiazepine consumers; (2) in the blood of cirrhotic treated or not with a non-absorbable antibiotic; (3) in several constituents of our diet. In conclusion, NBZDs increase sometime in cirrhotics with or without HE but they reach concentrations not higher than those found in commercial benzodiazepines consumers. Hence NBZDs must be considered as occasional precipitating factor of HE and benzodiazepine antagonists only symptomatic drugs. The finding that NBZDs may be in part synthesized by intestinal bacterial flora and in part constituent of our diet underlines the importance to feed cirrhotic patients with selected food.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  • Ahboucha S, Butterworth RF (2005) Role of endogenous benzodiazepine ligands and their GABA-A-associated receptor in hepatic encephalopathy. Met Brain Dis 20:425–437

    Article  CAS  Google Scholar 

  • Ahboucha S, Araqi F, Layrargues GP, Butterworth RF (2005) Differential effects of ammonia on the benzodiazepine modulatory site on the GABA-A receptor complex of human brain. Neurochem Int 47:58–63

    Article  PubMed  CAS  Google Scholar 

  • Ahboucha S, Pomier-Layargues G, Mamer O, Butterworth RF (2006) Increased levels of pregnenolone and its neuroactive metabolite allopregnanolone in autopsied brain tissue from cirrhotic patients who died in hepatic coma. Neurochem Intern 49:372–378

    Article  CAS  Google Scholar 

  • Albrect J, Norenberg MO (2006) Glutamine: a Trojan horse in ammonia neurotoxicity. Hepatology 44:788–794

    Article  CAS  Google Scholar 

  • Alho H, Fremeau RT, Tiedge H, Wilcox J, Bovolin P, Brosius J, Roberts JL, Costa E (1988) Diazepam Binding Inhibitor gene expression: location in brain and peripheral tissues of rat. Proc Natl Acad Sci U S A 85:7018–7022

    Article  PubMed  CAS  Google Scholar 

  • Anholt RRH, Pederson PL, De Souza EB, Snyder SH (1986) The peripheral-type benzodiazepine receptor: localization to the mitochondrial outer membrane. J Biol Chem 261:576–583

    PubMed  CAS  Google Scholar 

  • Antkiewicz-Michaluk L, Guidotti A, Krueger KE (1988) Molecular characterization and mitochondrial density of a recognition site for peripheral-type benzodiazepine ligands. Mol Pharmacol 34:272–278

    PubMed  CAS  Google Scholar 

  • Avallone R, Zanoli P, Corsi L, Cannazza G, Baraldi M (1996) Benzodiazepine-like compounds and GABA in flower heads of Matricaria chamomilla. Phytoter Res 10:177–179

    Google Scholar 

  • Avallone R, Zeneroli ML, Venturini I, Corsi L, Schreier P, Kleinschnitz M, Ferrarese C, Farina F, Baraldi C, Pecora N, Frigo M, Baraldi M (1998) Endogenous benzodiazepine-like compounds and diazepam binding inhibitor in serum of liver cirrhosis patients with and without encephalopathy. Gut 42:860–867

    Google Scholar 

  • Avallone R, Corsi L, Zeneroli ML, Baraldi M (2001) Presence of benzodiazepine like molecules in food and their implication in the nutrition of cirrhotic patients. Innov Food Sci Emerg Technol 2:193–198

    Article  CAS  Google Scholar 

  • Baktir GA, Fisch HU, Karlaganis G, Minder C, Bircher J (1987) Mechanism of the excessive sedative response of cirrhotics to benzodiazepine: model experiments with triazolam. Hepatology 7:629–638

    Article  Google Scholar 

  • Bansky G, Meier PJ, Riederer E, Walzer H, Ziegler WH, Schmid M (1989) Effects of the benzodiazepine antagonist flumazenil in hepatic encephalopathy in humans. Gastroenterology 97:744–750

    PubMed  CAS  Google Scholar 

  • Baraldi M (1990) Supersensitivity of GABA-A receptors in hepatic encephalopathy. Neurochem Res 6:669–671

    Google Scholar 

  • Baraldi M, Zeneroli ML (1982) Experimental hepatic encephalopathy: changes in the binding of y-aminobutyric acid. Science 16:427–428

    Article  Google Scholar 

  • Baraldi M, Caselgrandi E, Borella P, Zeneroli ML (1983a) Decrease of brain zinc in experimental hepatic encephalopathy. Brain Res 258:170–172

    Article  CAS  Google Scholar 

  • Baraldi M, Caselgrandi E, Borella P, Cremonini C, Zeneroli ML (1983b) Zinc content in brain tissues and GABA receptor function in experimental hepatic encephalopathy. In: Zbinden G (ed) Application of behavioural pharmacology in toxicology. Raven, New York, pp 243–250

    Google Scholar 

  • Baraldi M, Zeneroli ML, Ventura E, Penne A, Pinelli G, Ricci P, Penne A, Pinelli G, Ricci P, Santi M (1984a) Supersensitivity of benzodiazepine receptors in hepatic encephalopathy due to fulminant hepatic failure in the rat: reversal by benzodiazepine antagonist. Clin Sci 67:167–175

    PubMed  CAS  Google Scholar 

  • Baraldi M, Pinelli G, Ricci P, Zeneroli ML (1984b) Toxins in hepatic encephalopathy: the role of the synergistic effect of ammonia, mercaptans and short chain fatty acids. Arch Toxicol 7:103–106

    CAS  Google Scholar 

  • Baraldi M, Zeneroli ML, Ventura E, Vezzelli C (1987) An increase in cerebral benzodiazepine receptors induced by a subacute administration of ammonia, mercaptans and short-chain fatty acids in rats. Clin Sci 73:669–671

    PubMed  CAS  Google Scholar 

  • Baraldi M, Zeneroli ML, Rothstein JO (1991) Increased presence of benzodiazepine-like compounds in a rat model of hepatic encephalopathy. In: Bengtsson F, Jeppson B (eds) Progress in hepatic encephalopathy. CRC, Miami, pp 155–160

    Google Scholar 

  • Barbaccia ML, Berkovich A, Guarneri P, Slobodyansky E (1990) DBI (diazepam binding inhibitor): the precursor of a family of endogenous modulators of GABAA receptor function. History, perspectives, and clinical implications. Neurochem Res 15:161–168

    Article  PubMed  CAS  Google Scholar 

  • Basile AS, Gammal SH, Jones EA, Skolnick P (1989) GABA-A receptor complex in an experimental model of hepatic encephalopathy: evidence far elevated levels of an endogenous benzodiazepine receptor complex ligand. J Neurochem 53:1057–1063

    Article  PubMed  CAS  Google Scholar 

  • Basile AS, Hughes RD, Harrison PH, Murata Y, Pannell L, Jones EA, Williams R, Skolnick P (1991) Elevated brain concentrations of 1,4benzodiazepines in fulminant hepatic failure. N Engl J Med 325:473–478

    PubMed  CAS  Google Scholar 

  • Basile AS, Harrison PM, Hughes RD, Gu ZQ, Pannell L, McKinney A, Jones EA, Williams R (1994a) Relationship between plasma benzodiazepine receptor ligand concentrations and severity of hepatic encephalopathy. Hepatology 19:112–121

    PubMed  CAS  Google Scholar 

  • Basile AS, Harrison PM, Hughes RD, Gu ZQ, Pannell L, McKinney A, Jones EA (1994b) Relationship between plasma benzodiazepine receptor ligand concentrations and severity of hepatic encephalopathy. Hepatology 19:112–121

    Article  PubMed  CAS  Google Scholar 

  • Behar KL, Rothman DL, Petersen KF, Hooten M, Delaney R, Petroff OA, Shulman GI, Navarro V, Petrakis IL, Charney DS, Krystal JH (1999) Preliminary evidence of low cortical GABA levels in localized 1 H-MR spectra of alcohol-dependent and hepatic encephalopathy patients. Am J Psych 156:952–954

    CAS  Google Scholar 

  • Braestrup C, Squires RF (1977) Specific benzodiazepine receptors in rat brain characterized by high-affinity [3H]diazepam binding. Proc Natl Acad Sci USA 74:3805–3809

    Article  PubMed  CAS  Google Scholar 

  • Branch RA, Morgan MH, James J, Read AE (1976) Intravenous administration of diazepam in patients with chronic liver disease. Gut 17:975–983

    Article  PubMed  CAS  Google Scholar 

  • Butterworth RF, Lavoie J, Peterson C (1989) Excitatory amino acids and hepatic encephalopathy. In: Pomier Larargue G, Butterworth RF (eds) Hepatic encephalopathy: pathophysiology and treatment. Humana, Clifton, pp 417–433

    Google Scholar 

  • Butterworth RF, Tonon MC, Desy L, Giguere JF, Vaudry H, Pelletier G (1991) Increased brain content of the endogenous benzodiazepine receptor ligand, octadecaneuropeptide (ODN), following portacaval anastomosis in the rat. Peptides 12:119–125

    Article  PubMed  CAS  Google Scholar 

  • Cortelli P, Avallone R, Baraldi M, Zeneroli ML, Mandrioli J, Corsi L, Riva R, Tinuper P, Lugaresi L, Baruzzi A, Montagna P (2005) Endozepines in recurrent stupor. Sleep Med Rev XX:1–11

    Google Scholar 

  • Costa E, Guidotti A (1991) Diazepam binding inhibitor (DBI): a peptide with multiple biological actions. Life Sci 49:325–344

    Article  PubMed  CAS  Google Scholar 

  • Ferenci P, Pappas SC, Munson PJ, Jones EA (1984) Changes in glutamate receptors on synaptic membranes associated with hepatic encephalopathy or hyperammonemia in the rabbit. Hepatology 4:25–29

    Article  PubMed  CAS  Google Scholar 

  • Ferrarese C, Appollonio I, Bianchi G, Frigo M, Marzorati C, Pecora N, Perego M, Pierpaoli C, Frattola L (1993) Benzodiazepine receptors and diazepam binding inhibitor: a possible link between stress, anxiety and the immune system. Psychoneuroendocrinology 18:3–22

    Article  PubMed  CAS  Google Scholar 

  • Grimm G, Ferenci P, Katzenschlager R, Madl C, Schneeweiss B, Laggner AN, Lenz K, Gangl A (1988) Improvement of hepatic encephalopathy treated with flumazenil. Lancet 1:1392–1394

    Article  Google Scholar 

  • Guidotti A (1991) Role of DBI in brain and its posttranslational processing products in normal and abnormal behaviour. Neuropharmacology 12:1425–1433

    Google Scholar 

  • Guidotti A, Baraldi M, Costa E (1979) 1,4-Benzodiazepines and gamma-aminobutyric acid: pharmacological and biochemical correlates. Pharmacology 19:267–277

    Article  PubMed  CAS  Google Scholar 

  • Guidotti A, Forchetti CM, Corda MC, Konke D, Bennett CD, Costa E (1983) Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. Proc Natl Acad Sci U S A 80:3531–3535

    Article  PubMed  CAS  Google Scholar 

  • Gyr K, Meier R, Haussler J, Bouletreau P, Fleig WE, Gatta A, Holstege A, Pomier-Layrargues G, Schalm SW, Groeneweg M, Scollo-Lavizzari G, Ventura E, Zeneroli ML, Williams R, Yoo Y, Amrein R (1996) Evaluation of the efficacy and safety of flumazenil in the treatment of portal-systemic encephalopathy: a double blind, randomised, placebo controlled multicenter study. Gut 39:319–324

    Article  PubMed  CAS  Google Scholar 

  • Jalan R, Turjanski N, Taylor-Robinson SD, Koepp MJ, Richardson MP, Wilson JA, Bell JD, Brooks DJ (2000) Increased availability of central benzodiazepine receptors in patients with chronic hepatic encephalopathy and alcohol related cirrhosis. Gut 46:546–552

    Article  PubMed  CAS  Google Scholar 

  • King GL, Knox JJ, Oingledine R (1985) Reduction of inhibition by benzodiazepine antagonist, Ro 15-1788, in the rat hippocampal slice. Neuroscience 15:371–378

    Article  PubMed  CAS  Google Scholar 

  • Lambert JJ, Belelli D, Peden DR, Vardy AW, Peters JA (2003) Neurosteroid modulation of GABA-A receptors. Prog Neurobiol 71:67–80

    Article  PubMed  CAS  Google Scholar 

  • Lavoie J, Pomier Layrargues G, Butterworth RF (1990) Increased densities of peripheral-type benzodiazepine receptors in brain autopsy samples from cirrhotic patients with hepatic encephalopathy. Hepatology 11:874–882

    Article  PubMed  CAS  Google Scholar 

  • MacDonald GA, Frey KA, Agranoff BW, Minoshima S, Koeppe RA, Kuhl DE, Shulkin BL, Lucey MR (1997) Cerebral benzodiazepine receptor binding in vivo in patients with recurrent hepatic encephalopathy. Hepatology 26:277–282

    Article  PubMed  CAS  Google Scholar 

  • Medina JH, Pena C, Piva M, Paladini AC, De Robertis E (1988) Presence of benzodiazepine-like molecules in mammalian brain and milk. Biochem Biophys Res Comm 152:534–539

    Article  PubMed  CAS  Google Scholar 

  • Medina JH, Pena C, Levi de Stein M, Wolfman C, Paladini AC (1989) Benzodiazepine-like molecules as well as other ligands for the brain benzodiazepine receptors, are relatively common constituents of plants. Biochem Biophys Res Comm 165:547–553

    Article  PubMed  CAS  Google Scholar 

  • Moroni F, Lombardi G, Moneti G, Cortesini C (1983) The release and neosynthesis of glutamic acid are increased in experimental models of hepatic encephalopathy. J Neurochem 40:850–854

    Article  PubMed  CAS  Google Scholar 

  • Mullen KO, Martin JV, Mendelson WB, Bassett ML, Jones EA (1988) Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy. Lancet 1:457–459

    Article  PubMed  CAS  Google Scholar 

  • Mullen KD, Szauter KM, Kaminsky-Russ K (1990) Endogenous benzodiazepine activity in body fluids of patients with hepatic encephalopathy. Lancet 336:81–83

    Article  PubMed  CAS  Google Scholar 

  • Nayeem N, Green TP, Martin IL, Barnard EA (1994) Quaternary structure of the native GABA-A receptor determined by electron microscopic image analysis. J Neurochem 62:808–815

    Google Scholar 

  • Norenberg MD, Itzhak Y, Bender AS (1997) The peripheral benzodiazepine receptor and neurosteroids in hepatic encephalopathy. Adv Exp Med Biol 420:95–111

    PubMed  CAS  Google Scholar 

  • Oke BO, Suarez-Quian C, Riond J, Ferrero P, Papadopoulos V (1992) Cell surface localization of the peripheral-type benzodiazepine receptor (PBR) in adrenal cortex. Mol Cell Endocrinol 87:81–86

    Article  Google Scholar 

  • Olasmaa M, Guidotti A, Costa E, Rothstein JD, Goldman ME, Weber RJ, Paul SM (1989) Endogenous benzodiazepines in hepatic encephalopathy. Lancet 1:491–492

    Article  PubMed  CAS  Google Scholar 

  • Olasmaa M, Rothstein JD, Guidotti A, Weber RJ, Paul SM, Spector S, Zeneroli ML, Baraldi M, Costa E (1990) Endogenous benzodiazepine receptor ligands in human and animal hepatic encephalopathy. J Neurochem 55:2015–2023

    Article  PubMed  CAS  Google Scholar 

  • Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapère JJ, Lindemann P, Norenberg MD, Nutt D, Weizman A, Zhang MR, Gavish M (2006) Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci 27:402–409

    Article  PubMed  CAS  Google Scholar 

  • Payeur R, Lydiard RB, Ballenger JC, Laraia MT, Fossey MD, Zealberg J (1992) CSF diazepam binding inhibitor concentrations in panic disorders. Biol Psych 32:712–716

    Article  CAS  Google Scholar 

  • Pomier-Layrargues G, Giguere JF, Lavoie J, Perney P, Gagnon S, O’Amour M, Wells J, Butterworth RF (1994) Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo controlled crossover trial. Hepatology 19:32–37

    PubMed  CAS  Google Scholar 

  • Rothstein JH, Guidotti A (1993) Endozepines: non-benzodiazepine endogenous allosteric modulators of GABA receptors. In: lzquierdo I, Medina J (ed.) Natural occurring benzodiazepines structure. Ellis Horwood, London, pp. 115–130

  • Rothstein JD, Mckhann G, Guarnieri P, Barbaccia ML, Guidotti A, Costa E (1989) Cerebrospinal fluid content of diazepam binding inhibitor (DBI) in chronic hepatic encephalopathy. Ann Neurol 26:57–62

    Article  PubMed  CAS  Google Scholar 

  • Rothstein JO, Garland W, Puia G, Guidotti A, Costa E (1991) The role of endogenous benzodiazepine receptor ligands in physiology and pathology. In: Barnard EA, Costa E (eds) Transmitter amino acid receptors: structures, transduction and models for drug development. Thieme, New York, pp 325–339

    Google Scholar 

  • Rothstein JO, Garland W, Puia G, Guidotti A, Weber RJ, Costa E (1992a) Purification and characterisation of naturally occurring benzodiazepine receptor ligands in rat and human brain. J Neurochem 58:2102–2115

    Article  PubMed  CAS  Google Scholar 

  • Rothstein JO, Guidotti A, Costa E (1992b) Release of endogenous benzodiazepine receptor ligands (endozepines) from cultured neurons. Neurosci Lett 143:210–214

    Article  PubMed  CAS  Google Scholar 

  • Sangameswaran L, De Blas A (1985) Demonstration of benzodiazepine-like molecules in the mammalian brain with a monoclonal antibody to benzodiazepines. Proc Natl Acad Sci U S A 82:5560–5564

    Article  PubMed  CAS  Google Scholar 

  • Sangameswaran L, Fales HM, Friedrich P, De Blas AL (1986) Purification of a benzodiazepine from bovine brain and detection of benzodiazepine-like immunoreactivity in human brain. Proc Natl Acad Sci U S A 83:9236–9240

    Article  PubMed  CAS  Google Scholar 

  • Schafer DF, Jones EA (1982) Potential neural mechanisms in the pathogenesis of hepatic encephalopathy. In: Popper H, Schaffner F (eds) Progress in liver diseases vol 7. Grune & Stratton, New York, pp 615–627

    Google Scholar 

  • Scollo-Lavizzari G, Steinrnann E (1985) Reversal of hepatic coma by benzodiazepine antagonist (Ro 15–1788). Lancet 1:1324

    Article  Google Scholar 

  • Unseld E, Krishna OR, Fischer C, Klotz U (1989) Detection of desmethyldiazepam and diazepam in brain of different species and plants. Biochem Pharmacol 38:2473–2478

    Article  PubMed  CAS  Google Scholar 

  • Venturini I, Zeneroli ML, Corsi L, Avallone R, Farina F, Alho H, Baraldi C, Ferrarese C, Pecora N, Frigo M, Ardizzone G, Arrigo A, Pellicci BR, Baraldi M (1998) Up-regulation of peripheral benzodiazepine receptor system in hepatocellular carcinoma. Life Sci 63:1267–277

    Article  Google Scholar 

  • Verma A, Nye J, Snyder SH (1987) Porphyrins are endogenous ligands for the mitochondrial (peripheral-type) benzodiazepine receptor. Proc Natl Acad Sci U S A 84:2256–2260

    Article  PubMed  CAS  Google Scholar 

  • Vicini S, Alho H, Costa E, Mienville JM, Santi MR, Vaccarino FM (1986) Modulation of y-aminobutyric acid-mediated inhibitory synaptic currents in dissociated cortical cell cultures. Proc Natl Acad Sci U S A 83:9269–9273

    Article  PubMed  CAS  Google Scholar 

  • Wieland HA, Loddens H, Seeburg PH (1992) A single histidine in GABA-A receptors is essential for benzodiazepine agonist binding. J Biol Chem 267:1426–1429

    PubMed  CAS  Google Scholar 

  • Wildmann J (1988) Increase of natural benzodiazepines in wheat and potato during germination. Biochem Bioph Res Comm 157:1436–1443

    Article  CAS  Google Scholar 

  • Woods MJ, Zisterer DM, Williams DC (1996) Two cellular and subcellular locations for the peripheral-type benzodiazepine receptor in rat liver. Biochem Pharmacol 51:1283–1292

    Article  PubMed  CAS  Google Scholar 

  • Zaman SH (1990) Endogenous steroids and pathogenesis of hepatic encephalopathy. Lancet 336:573–574

    Article  PubMed  CAS  Google Scholar 

  • Zanoli P, Giacobazzi A, Vaccari G, Zeneroli ML, Baraldi M (1991) Up-regulation of peripheral benzodiazepine receptors in brain areas of rats with galactosamine-induced hepatic encephalopathy. In: Bengtsson F, Jeppson B (eds) Progress in hepatic encephalopathy. CRC, Miami, pp 161–168

    Google Scholar 

  • Zeneroli ML, Iuliano E, Racagni G, Baraldi M (1982a) Metabolism of gamma-aminobutyric add and brain uptake in galactosamine induced hepatic encephalopathy. J Neurochem 33:1219–1222

    Article  Google Scholar 

  • Zeneroli ML, Ventura E, Baraldi M, Penne A, Messori E, Zieve L (1982b) Visual evoked potentials in encephalopathy induced by galactosamine, ammonia, dimethyldisulfide and octanoic acid. Hepatology 2:532–538

    Article  PubMed  CAS  Google Scholar 

  • Zeneroli ML, Venturini I, Avallone R, Farina F, Corsi L, Ardizzone G, Centanaro M, Arrigo A, Baraldi M (1996) Hepatic encephalopathy in liver transplant recipients precipitated by benzodiazepines present in transfused blood. Transplantation 62:764–767

    Article  PubMed  CAS  Google Scholar 

  • Zeneroli ML, Venturini I, Stefanelli S, Farina F, Cosenza R, Miglioli L, Minelli E, Amedei R, Ferrieri A, Avallone R, Baraldi M (1997) Antibacterial activity of rifaximin reduces the levels of benzodiazepine-like compounds in patients with liver cirrhosis. Pharmacol Res 35:557–560

    Article  PubMed  CAS  Google Scholar 

  • Zeneroli ML, Avallone R, Corsi L, Venurini I, Baraldi C, Baraldi M (2005) Management of hepatic encephalopathy: role of rifaximin. Chemotherapy 51:90–105

    Article  PubMed  CAS  Google Scholar 

  • Zieve L, Doizaki WM, Zieve FJ (1874) Synergism between mercaptans and ammonia or fatty acids in the production of coma: a possible role for mercaptans in the pathogenesis of hepatic coma. J Lab Clin Med 83:16–28

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biomedical Sciences (Section of Pharmacology), University of Modena and Reggio Emilia, Via Campi 287, 41100, Modena, Italy

    M. Baraldi, R. Avallone & L. Corsi

  2. Department of Internal Medicine, University of Modena and Reggio Emilia, Via Campi 287, 41100, Modena, Italy

    I. Venturini & M. L. Zeneroli

  3. Department of Surgery (Transplantation Unit), University of Modena and Reggio Emilia, Modena, Italy

    C. Baraldi

Authors
  1. M. Baraldi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Avallone
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. Corsi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. I. Venturini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. Baraldi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. L. Zeneroli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Baraldi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baraldi, M., Avallone, R., Corsi, L. et al. Natural endogenous ligands for benzodiazepine receptors in hepatic encephalopathy. Metab Brain Dis 24, 81–93 (2009). https://doi.org/10.1007/s11011-008-9111-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11011-008-9111-8

Keywords

Search

Navigation